Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil
- PMID: 31597193
- DOI: 10.1002/hep.30984
Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil
Comment in
-
Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and Immunosuppressive Drugs: Causality of Mycophenolate Mofetil or Tacrolimus?Hepatology. 2021 Jun;73(6):2615-2616. doi: 10.1002/hep.31633. Epub 2021 May 21. Hepatology. 2021. PMID: 33185905 No abstract available.
-
REPLY.Hepatology. 2021 Jun;73(6):2616. doi: 10.1002/hep.31635. Hepatology. 2021. PMID: 33200416 No abstract available.
References
-
- Kaltenborn A, Schrem H. Mycophenolate mofetil in liver transplantation: a review. Ann Transplant 2013;18:685-696.
-
- Weber NT, Sigaroudi A, Ritter A, Boss A, Lehmann K, Goodman D, et al. Intractable ascites associated with mycophenolate in a simultaneous kidney-pancreas transplant patient: a case report. BMC Nephrol 2017;18:360.
-
- EASL. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol 2016;64:179-202.
-
- Schouten JN, Verheij J, Seijo S. Idiopathic non-cirrhotic portal hypertension: a review. Orphanet J Rare Dis 2015;10:67.
-
- Guo D, Pang LF, Han Y, Hang H, Wang G, Tan ZR, et al. Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers. Eur J Clin Pharmacol 2013;69:843-849.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources